FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
FUSN
Delisted
FUSN was delisted on the 3rd of June, 2024.
31 hedge funds and large institutions have $61.3M invested in Fusion Pharmaceuticals Inc. Common Shares in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
Holders
31
Holding in Top 10
2
Calls
$1K
Puts
–
Top Buyers
| 1 | +$172K | |
| 2 | +$29K | |
| 3 | +$8K | |
| 4 |
HFS
Heritage Financial Services
Westwood,
Massachusetts
|
+$2K |
| 5 |
SCM
Sio Capital Management
New York
|
+$1.71K |
Top Sellers
| 1 | -$435K | |
| 2 | -$345K | |
| 3 | -$200K | |
| 4 |
Morgan Stanley
New York
|
-$112K |
| 5 |
PBPIA
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
-$93.1K |